Van Ranst M - Search Results

1

Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients.

Van Vaerenbergh K, Harrer T, Schmit JC, Carbonez A, Fontaine E, Kurowski M, Grünke M, Löw P, Rascu A, Schmidt B, Schmitt M, Thoelen I, Walter H, Van Laethem K, Van Ranst M, Desmyter J, De Clercq E, Vandamme AM. Van Vaerenbergh K, et al. Among authors: van laethem k, van ranst m. AIDS Res Hum Retroviruses. 2002 Apr 10;18(6):419-26. doi: 10.1089/088922202753614182. AIDS Res Hum Retroviruses. 2002. PMID: 11958685

2

Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.

Van Cutsem E, Snoeck R, Van Ranst M, Fiten P, Opdenakker G, Geboes K, Janssens J, Rutgeerts P, Vantrappen G, de Clercq E, et al. Van Cutsem E, et al. Among authors: van ranst m. J Med Virol. 1995 Feb;45(2):230-5. doi: 10.1002/jmv.1890450221. J Med Virol. 1995. PMID: 7775945

3

Post-exposure prophylaxis after accidental prion inoculation.

Van Ranst M, Desmyter J. Van Ranst M, et al. Lancet. 1998 Feb 21;351(9102):600. doi: 10.1016/S0140-6736(05)78592-5. Lancet. 1998. PMID: 9492810 No abstract available.

4

Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].

Snoeck R, Wellens W, Desloovere C, Van Ranst M, Naesens L, De Clercq E, Feenstra L. Snoeck R, et al. Among authors: van ranst m. J Med Virol. 1998 Mar;54(3):219-25. doi: 10.1002/(sici)1096-9071(199803)54:3<219::aid-jmv13>3.0.co;2-c. J Med Virol. 1998. PMID: 9515772

5

African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies.

Vandamme AM, Salemi M, Van Brussel M, Liu HF, Van Laethem K, Van Ranst M, Michels L, Desmyter J, Goubau P. Vandamme AM, et al. Among authors: van laethem k, van brussel m, van ranst m. J Virol. 1998 May;72(5):4327-40. doi: 10.1128/JVI.72.5.4327-4340.1998. J Virol. 1998. PMID: 9557723 Free PMC article.

6

Long-term stability of human immunodeficiency virus viral load and infectivity in whole blood.

Vandamme AM, Van Laethem K, Schmit JC, Van Wijngaerden E, Reynders M, Debyser Z, Witvrouw M, Van Ranst M, De Clercq E, Desmyter J. Vandamme AM, et al. Among authors: van laethem k, van wijngaerden e, van ranst m. Eur J Clin Invest. 1999 May;29(5):445-52. doi: 10.1046/j.1365-2362.1999.00462.x. Eur J Clin Invest. 1999. PMID: 10354202

7

Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir.

Van Laethem K, Witvrouw M, Balzarini J, Schmit JC, Sprecher S, Hermans P, Leal M, Harrer T, Ruiz L, Clotet B, Van Ranst M, Desmyter J, De Clercq E, Vandamme AM. Van Laethem K, et al. Among authors: van ranst m. AIDS. 2000 Mar 10;14(4):469-71. doi: 10.1097/00002030-200003100-00027. AIDS. 2000. PMID: 10770556 No abstract available.

8

Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations.

Van Laethem K, Van Vaerenbergh K, Schmit JC, Sprecher S, Hermans P, De Vroey V, Schuurman R, Harrer T, Witvrouw M, Van Wijngaerden E, Stuyver L, Van Ranst M, Desmyter J, De Clercq E, Vandamme AM. Van Laethem K, et al. Among authors: van vaerenbergh k, van wijngaerden e, van ranst m. J Acquir Immune Defic Syndr. 1999 Oct 1;22(2):107-18. doi: 10.1097/00126334-199910010-00001. J Acquir Immune Defic Syndr. 1999. PMID: 10843523

9

Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients.

Van Laethem K, Schmit JC, Pelemans H, Balzarini J, Witvrouw M, Pérez-Pérez MJ, Camarasa MJ, Esnouf RM, Aquaro S, Cenci A, Perno CF, Hermans P, Sprecher S, Ruiz L, Clotet B, Van Wijngaerden E, Van Ranst M, Desmyter J, De Clercq E, Vandamme AM. Van Laethem K, et al. Among authors: van wijngaerden e, van ranst m. AIDS Res Hum Retroviruses. 2000 Jun 10;16(9):825-33. doi: 10.1089/08892220050042765. AIDS Res Hum Retroviruses. 2000. PMID: 10875608

10

Prevalence of CCR5 and CCR2 HIV-coreceptor gene polymorphisms in Belgium.

Struyf F, Thoelen I, Charlier N, Keyaerts E, Van der Donck I, Wuu J, Van Ranst M. Struyf F, et al. Among authors: van der donck i, van ranst m. Hum Hered. 2000 Sep-Oct;50(5):304-7. doi: 10.1159/000022932. Hum Hered. 2000. PMID: 10878474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

461 results

Search Page

Filters